Bacillary dysentery is an intestinal infection caused by bacteria in the genus Shigella, and it remains one of the most common causes of bloody diarrhea worldwide. The bacteria spread easily through contaminated water, food, or direct person-to-person contact, and they are remarkably efficient at invading the lining of the large intestine. Even a tiny dose of the organism can trigger illness, which is part of what makes it so persistent in crowded or resource-limited settings. But the story of bacillary dysentery is more complicated than “bad water, bad outcome,” touching on rising drug resistance, surprising routes of transmission, and long-term consequences that researchers are only beginning to quantify.
The Bacteria Behind It
Four species of Shigella cause bacillary dysentery: S. dysenteriae, S. flexneri, S. sonnei, and S. boydii. They are not all equally dangerous or equally common. S. dysenteriae type 1 produces a potent toxin called Shiga toxin and is responsible for the most severe outbreaks, with the highest death rates. S. flexneri is the predominant species in low-income countries and regions with poor sanitation, while S. sonnei tends to dominate in wealthier, more urbanized settings.1PubMed Central. Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence As countries improve economically, researchers have observed a shift: S. sonnei gradually replaces S. flexneri as the leading cause, a pattern confirmed by surveillance data from both urban and rural regions.2PubMed Central. Shigella sonnei and Shigella flexneri: Epidemiology supporting development of cross-protective vaccines – Section: Distribution of Shigella
An interesting wrinkle: genetically, Shigella species are not truly separate from Escherichia coli. Their DNA is roughly 80 to 90 percent similar, and Shigella are essentially strains of E. coli that acquired a specific set of virulence genes carried on a large plasmid.3PubMed Central. Accurate differentiation of Escherichia coli and Shigella serogroups: challenges and strategies – Section: Evolution of Shigella Species They were classified as their own genus decades ago because of how they behave clinically, but from an evolutionary standpoint, the distinction is somewhat artificial. This close relationship also complicates laboratory identification, which matters for diagnosis.
How Shigella Gets Inside You
The classic route of transmission is fecal-oral: someone with the infection sheds the bacteria in their stool, and those bacteria end up in another person’s mouth through contaminated hands, food, or water. What makes Shigella especially troublesome is its infectious dose. While many gut pathogens require hundreds of thousands or millions of organisms to cause illness, Shigella can do so with as few as 10 to 100 bacteria. That low threshold means a lapse in hand hygiene after using the bathroom, or a shared surface in a daycare center, can easily start a chain of infection.
Contaminated water supplies and lack of sanitation infrastructure drive large outbreaks in low-income countries, refugee camps, and disaster-affected areas. But bacillary dysentery is not exclusively a disease of poverty. Outbreaks occur in industrialized countries too, often in institutional settings such as daycare facilities, nursing homes, and prisons where close contact is unavoidable.
Sexual Transmission and High-Risk Groups
A route of transmission that gets less public attention is sexual. In high-income countries, clusters of Shigella infection have been increasingly documented among men who have sex with men (MSM), driven primarily by direct or indirect oral-anal contact. A case-control study in San Francisco found that MSM status was the strongest risk factor for shigellosis among men, with roughly eight times the odds compared to controls, and direct oral-anal contact independently increased risk about sevenfold.4Clinical Infectious Diseases. Case-Control Study of Shigellosis in San Francisco: The Role of Sexual Transmission and HIV Infection HIV infection was also independently associated, likely because of increased susceptibility rather than exposure alone.
A systematic review of sexually transmitted shigella in MSM identified several associated factors, including living with HIV, having a concurrent sexually transmitted infection, using PrEP, and attending sex-on-premises venues. The review also found that sexually transmitted strains were more likely to be drug-resistant, including strains with reduced susceptibility to azithromycin.5Sexually Transmitted Infections. Factors associated with sexually transmitted shigella in men who have sex with men: a systematic review – Section: Results Outbreaks of a primarily clonal strain of S. flexneri serotype 1 have been tracked in cities like Vancouver, placing a substantial burden on healthcare systems through hospital admissions.6PubMed. Shigella flexneri serotype 1 infections in men who have sex with men in Vancouver, Canada Understanding this route matters because prevention messaging targeted only at food and water safety misses a significant proportion of cases in urban, high-income settings.
What Shigella Does Once Inside the Gut
Once swallowed, Shigella bacteria survive the acidic environment of the stomach and reach the large intestine, where they invade the epithelial cells lining the colon. They do this using a molecular syringe, a structure called a type III secretion system, which punctures the host cell membrane and injects proteins that hijack the cell’s own machinery.7PubMed Central. The inside story of Shigella invasion of intestinal epithelial cells – Section: Abstract These injected proteins force the cell to rearrange its internal skeleton and essentially pull the bacterium inside.8PubMed Central. Shigella promotes major alteration of gut epithelial physiology and tissue invasion by shutting off host intracellular transport
Once inside a cell, Shigella does something particularly clever: it co-opts the cell’s own structural fibers to propel itself through the cell body and push into neighboring cells. The bacteria assemble rocket-like tails of actin filaments behind them, generating enough force to create finger-like protrusions in the cell membrane that the adjacent cell then engulfs.9PubMed Central. Requirement for formin-induced actin polymerization during spread of Shigella flexneri This cell-to-cell movement lets the bacteria spread through the tissue without ever returning to the outside environment, which helps them dodge the immune system’s antibodies circulating in the gut.
The result of all this invasion is intense inflammation. The immune system responds aggressively, flooding the infected tissue with white blood cells. That inflammatory response is what causes the hallmark symptoms: bloody, mucus-laden diarrhea and severe cramping. Paradoxically, the immune response itself does much of the tissue damage.
Symptoms and How They Progress
Symptoms usually begin one to three days after exposure. Most cases start with watery diarrhea, fever, and abdominal cramps. Within a day or two, the diarrhea in classic dysentery becomes bloody and mucoid, with frequent, painful urges to use the bathroom even when the bowel is nearly empty (a sensation called tenesmus). Stools become small in volume but frequent, sometimes more than 20 times a day.
The severity varies by species. S. sonnei infections tend to be the mildest, often presenting as watery diarrhea without blood and resolving in a few days. S. flexneri and S. dysenteriae typically produce more severe illness. S. dysenteriae type 1, in particular, can cause systemic complications including dangerous electrolyte imbalances and seizures, especially in young children.10PubMed Central. Shigella: A Highly Virulent and Elusive Pathogen Dehydration is a constant concern, and in malnourished children in low-income settings, even a moderate case can become life-threatening.
One diagnostic challenge is that the clinical picture of bacillary dysentery overlaps with intestinal amebiasis, caused by the parasite Entamoeba histolytica. Both can produce bloody diarrhea and abdominal pain. However, shigellosis tends to show more white blood cells in the stool (a sign of bacterial infection), whereas amebiasis more often presents with alkaline stool and fewer fecal leukocytes.11PubMed Central. Comparison of clinical and laboratory characteristics of intestinal amebiasis with shigellosis among patients visiting a large urban diarrheal disease hospital in Bangladesh Laboratory testing is needed to distinguish them reliably.
Serious Complications
Most cases of bacillary dysentery resolve without lasting damage, but serious complications do occur. The most dangerous is hemolytic uremic syndrome (HUS), a condition in which the toxin damages blood vessel walls, triggers abnormal blood clotting in small vessels, and leads to kidney failure. HUS develops in roughly 8 percent of people infected with S. dysenteriae type 1 that produces Shiga toxin.12PubMed Central. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease The toxin works by shutting down protein production inside cells lining small blood vessels, causing massive cell death, activating clotting inside capillaries, and eventually leading to organ failure.13PubMed Central. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
Reactive arthritis is another recognized complication. Weeks after the gut infection clears, some people develop joint pain, swelling, and sometimes eye inflammation. This is thought to be an immune-mediated reaction rather than direct bacterial invasion of the joints, and it has been documented following infections with S. flexneri, S. sonnei, and even S. dysenteriae type 1.14PubMed Central. Reactive Arthritis due to Shigella Infection after a Visit to Egypt: A Late Complication of an Intestinal Infection People carrying the HLA-B27 genetic marker are thought to be at higher risk, though reactive arthritis can occur in anyone.
Childhood Stunting and Long-Term Growth
Beyond the acute illness, repeated or severe Shigella infections in early childhood carry consequences that persist long after the diarrhea stops. A systematic review found that Shigella is associated with persistent diarrhea, reduced linear growth, and economic impact on affected families.15PubMed Central. Consequences of Shigella infection in young children: a systematic review – Section: Results The greatest losses in height-for-age occurred in children who had cumulative infections over their first two years of life.
There is a hopeful finding embedded in this research, though. When toddlers with Shigella-positive diarrhea received appropriate antibiotic treatment, the growth decline was about four times smaller than in untreated children, suggesting that timely treatment can meaningfully reduce the stunting impact.16PubMed Central. Shigella and childhood stunting: Evidence, gaps, and future research directions This finding carries real weight for public health policy in settings where antibiotic access for childhood diarrhea is inconsistent.
Diagnosis Is Harder Than It Sounds
The traditional way to confirm Shigella infection is stool culture: growing the bacteria on selective media in a laboratory. The problem is that stool culture misses a lot of cases. The bacteria are fragile, and samples that sit for even a few hours without proper handling lose viability. In one large study of children with moderate-to-severe diarrhea in low-income countries, a quantitative PCR test targeting a Shigella gene detected 90 percent more cases than conventional culture did.17PubMed Central. Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries
A clinical evaluation of a multiplex real-time PCR assay showed 100 percent sensitivity for detecting Shigella after discrepant results were resolved, compared to culture sensitivity that ranged from about 53 to 77 percent depending on the pathogen.18PubMed Central. Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin-producing Escherichia coli isolates in stool specimens Work in Burkina Faso similarly found that PCR picked up far more Shigella cases than culture, identifying 17 cases where culture found only 5.19Sudan Journal of Medical Sciences. Molecular diagnosis of Shigella, Salmonella and Campylobacter by multiplex Real-time PCR in stool culture samples in Ouagadougou (Burkina Faso) The implication is that the true burden of Shigella disease has been historically undercounted, and many cases have gone undiagnosed.
Treatment and the Growing Problem of Drug Resistance
Mild shigellosis often resolves on its own with fluids and rest. For moderate-to-severe cases, antibiotics shorten the illness, reduce transmission, and, as noted above, may protect children against growth faltering. The catch is that Shigella has been accumulating resistance to antibiotics at an alarming pace.
Surveillance in Bangladesh found that more than 60 percent of recent Shigella isolates were resistant to three or more standard drugs, with significant increases in resistance to commonly used antibiotics over a decade-long period. Resistance to newer agents like azithromycin and even ceftriaxone had started to appear.20PubMed Central. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin The situation has only worsened since. A review of global resistance patterns noted that strains resistant to ciprofloxacin, azithromycin, and ceftriaxone simultaneously, the three first-line drugs for infectious diarrhea, have emerged worldwide and spread through travel, trade, and sexual networks. Some strains have even developed resistance to colistin, a last-resort antibiotic.21PubMed Central. Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts
In France, researchers documented a dramatic rise in extensively drug-resistant S. sonnei beginning around 2015. Genomic analysis traced the lineage to a ciprofloxacin-resistant sublineage that originally developed in South Asia, then acquired azithromycin resistance through plasmid transfer, and finally picked up various genes encoding resistance to third-generation cephalosporins.22Nature Communications. Rapid emergence of extensively drug-resistant Shigella sonnei in France – Section: Results and discussion This kind of stepwise accumulation of resistance genes is what makes Shigella a growing concern for clinicians: the treatment options are narrowing, and the bacteria keep adapting.
In malnourished children, zinc supplementation alongside standard treatment has shown benefit. A trial in Bangladesh found that children receiving zinc recovered about 50 percent faster than controls, gained more weight during recovery, and had fewer diarrheal episodes over the following six months.23PubMed. Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh – Section: Results Zinc does not replace antibiotics, but it appears to support gut healing and immune function during and after infection.
Prevention and Its Limits
The classic advice for preventing bacillary dysentery is straightforward: wash your hands with soap after using the toilet and before handling food, drink safe water, and practice proper food hygiene. This advice works. A study that promoted hand washing in households with confirmed Shigella cases found that the secondary infection rate dropped from about 32 percent in control households to 10 percent in the hand-washing group, and symptomatic cases fell from 14 percent to 2 percent.24Transactions of the Royal Society of Tropical Medicine and Hygiene. Communication Interruption of shigellosis by hand washing
But researchers have found that household-level water, sanitation, and hygiene (WASH) interventions have limits. Large cluster-randomized trials, including the WASH Benefits and SHINE studies, showed surprisingly modest effects on diarrheal disease when interventions were implemented at the household level without broader community coverage.25Acta Biology Forum. The Role of Water, Sanitation, and Hygiene (WASH) in Preventing Infectious Diseases: A Review of the Evidence One study specifically measuring immune markers of Shigella exposure in young children found that intensive household WASH combined with nutrition interventions did not reduce the proportion of children who had been exposed to the bacteria.26PubMed Central. Effects of improved water, sanitation, handwashing and nutrition on early childhood IgG immune repertoire development against Shigella and enteroinvasive Escherichia coli (EIEC) The implication is not that handwashing and clean water are useless, far from it. Rather, Shigella‘s extremely low infectious dose means that even small gaps in community-wide sanitation can sustain transmission, and individual household improvements cannot fully compensate.
For travelers visiting endemic areas, practical prevention includes drinking bottled or boiled water, avoiding raw vegetables and fruit you did not peel yourself, and being diligent about hand hygiene. For MSM, awareness that Shigella can spread through sexual contact is important; barrier methods and hand washing before and after sexual activity reduce risk.
Where Vaccine Development Stands
No licensed Shigella vaccine is available yet, but the field is more active than it has ever been. Multiple candidates are in clinical trials using different approaches, including live-attenuated bacteria, protein-based formulations, glycoconjugate vaccines, and a newer platform called GMMA (generalized modules for membrane antigens).27PubMed. Clinical development of human vaccine candidates against Shigella flexneri: a systematic review of clinical trials A systematic review of 24 clinical trials found that most candidates were safe and generated measurable immune responses. Glycoconjugate vaccines tended to produce longer-lasting antibody responses, while live-attenuated vaccines triggered broader immune activation at the mucosal level, closer to where Shigella actually invades.
The frustration is that only one candidate has made it to a Phase III efficacy trial, and direct comparisons between platforms are difficult because studies have used different dosing schedules, immune markers, and follow-up periods.27PubMed. Clinical development of human vaccine candidates against Shigella flexneri: a systematic review of clinical trials Still, several candidates have advanced into Phase II and III trials across multiple regions.28PubMed. Accelerating Shigella vaccines: from decades of research to global access Given the worsening antibiotic resistance landscape, a working vaccine would transform the fight against bacillary dysentery. The need is most urgent for children under five in low-income countries, who bear the heaviest burden, but a vaccine could also benefit travelers, military personnel, and MSM communities experiencing outbreaks.
What Shigella Does to the Gut Microbiome
Emerging research suggests that Shigella infection does not just damage the intestinal lining; it reshapes the microbial community living in the gut. An animal study found that oral infection with S. flexneri rapidly and significantly altered the gut microbiota, decreasing the abundance of beneficial bacteria such as Lactobacillus while increasing potentially harmful groups. Probiotic species like Lactobacillus reuteri showed significantly reduced abundance after infection.29PubMed Central. Dynamic comparison of gut microbiota of mice infected with Shigella flexneri via two different infective routes Whether these shifts contribute to the persistent diarrhea and growth problems seen in repeatedly infected children is an active area of investigation, and it raises the question of whether probiotic supplementation could eventually play a role in recovery alongside antibiotics and zinc. That work is still early, but the finding that infection disrupts the gut ecosystem well beyond the acute illness adds another layer to why Shigella carries consequences that outlast the fever and cramping.